Abstract
A novel coronavirus (2019-nCov) has wreak havoc across the globe, especially in the USA, Italy, Spain, France, Iran, UK, and China. The coronavirus infection has caused a pandemic (COVID-19), which is an acute infectious pneumonia of the 21st Century. 2019-nCov, being novel in nature has brought the world to a standstill and forced a global health emergency, which is attributed to the unavailability of viable antiviral drug, and the only options left are supportive care and non-specific treatment to improve the symptomatic conditions of patients. But still, it is not a permanent solution and there is a need to find an effective antiviral drug. The earlier reported SARS-CoV and recently emerged SARS-CoV-2 have similar homology in terms of epidemiology, genomics and pathogenesis, and it has been observed that the SARS-CoV was contained by Traditional Chinese Medicine (TCM). Thus, this review summarizes the information on natural traditional medicine, including Indian Ayurvedic Medicine and TCM having antiviral potential which have been used to control earlier pandemics, and their candidacy for the new drug development to control the COVID-19. In the wake of the current unprecedented situation, it is imperative to find effective and novel anti-SARS-CoV-2 agents by exploring traditional medicine which would be highly precise in action with minimal side effects.
Keywords: Traditional medicine, COVID-19, SARS-CoV-2, antiviral, ayurvedic medicine, chinese medicine, pandemic.
Current Traditional Medicine
Title:Traditional Medicine - A Possible Stop Codon for COVID-19
Volume: 7 Issue: 4
Author(s): Nissar A. Reshi, Anup S. Deshpande, Namita A. Raytekar and Vasudeo P. Zambare*
Affiliation:
- Department of Life Sciences, School of Science, Sandip University, Nashik, Maharashtra,India
Keywords: Traditional medicine, COVID-19, SARS-CoV-2, antiviral, ayurvedic medicine, chinese medicine, pandemic.
Abstract: A novel coronavirus (2019-nCov) has wreak havoc across the globe, especially in the USA, Italy, Spain, France, Iran, UK, and China. The coronavirus infection has caused a pandemic (COVID-19), which is an acute infectious pneumonia of the 21st Century. 2019-nCov, being novel in nature has brought the world to a standstill and forced a global health emergency, which is attributed to the unavailability of viable antiviral drug, and the only options left are supportive care and non-specific treatment to improve the symptomatic conditions of patients. But still, it is not a permanent solution and there is a need to find an effective antiviral drug. The earlier reported SARS-CoV and recently emerged SARS-CoV-2 have similar homology in terms of epidemiology, genomics and pathogenesis, and it has been observed that the SARS-CoV was contained by Traditional Chinese Medicine (TCM). Thus, this review summarizes the information on natural traditional medicine, including Indian Ayurvedic Medicine and TCM having antiviral potential which have been used to control earlier pandemics, and their candidacy for the new drug development to control the COVID-19. In the wake of the current unprecedented situation, it is imperative to find effective and novel anti-SARS-CoV-2 agents by exploring traditional medicine which would be highly precise in action with minimal side effects.
Export Options
About this article
Cite this article as:
Reshi A. Nissar, Deshpande S. Anup , Raytekar A. Namita and Zambare P. Vasudeo *, Traditional Medicine - A Possible Stop Codon for COVID-19, Current Traditional Medicine 2021; 7 (4) . https://dx.doi.org/10.2174/2215083806999201130103521
DOI https://dx.doi.org/10.2174/2215083806999201130103521 |
Print ISSN 2215-0838 |
Publisher Name Bentham Science Publisher |
Online ISSN 2215-0846 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
In Vitro Data of Current Therapies for SARS-CoV-2
Current Medicinal Chemistry Treatment of Disorders Characterized by Reversible Airway Obstruction in Childhood: are Anti-cholinergic Agents the Answer?
Current Pharmaceutical Design Ligand and Structure-based Virtual Screening of Lamiaceae Diterpenes with Potential Activity against a Novel Coronavirus (2019-nCoV)
Current Topics in Medicinal Chemistry Advances and Challenges in the Synthesis of Highly Oxidised Natural Phenols with Antiviral, Antioxidant and Cytotoxic Activities
Current Medicinal Chemistry New Approaches to Drug-DNA Interactions Based on Graphical Representation and Numerical Characterization of DNA Sequences
Current Computer-Aided Drug Design History and Global Status of the New Coronavirus Covid-2019 and Aspects of Previous Infections of SARS-CoV and MERS-CoV: A Systematic Review
Coronaviruses Impact of COVID-19 on Indian Pharmaceutical Industry and Way Forward
Infectious Disorders - Drug Targets Anti-Respiratory Syncytial Virus Mechanism of <i>Houttuynia cordata</i> Thunb Exploration based on Network Pharmacology
Combinatorial Chemistry & High Throughput Screening A Study About the Impact of Weather, Life Expectancy and Tourism on the Transmission of COVID-19
Coronaviruses In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases
Infectious Disorders - Drug Targets Clarification of Interaction Mechanism of Mouse Hepatitis Virus (MHV) N and nsp3 Protein with Homology Modeling and Protein-Protein Docking Analysis
Current Computer-Aided Drug Design Synthetic Genomics and Synthetic Biology Applications Between Hopes and Concerns
Current Genomics Deep Transfer Learning for COVID-19 Prediction: Case Study for Limited Data Problems
Current Medical Imaging The Antiviral and Antimalarial Drug Repurposing in Quest of Chemotherapeutics to Combat COVID-19 Utilizing Structure-Based Molecular Docking
Combinatorial Chemistry & High Throughput Screening Biomedical Devices for Pathogen Detection Using Microfluidic Chips
Current Proteomics Drug Targets in Severe Acute Respiratory Syndrome (SARS) Virus and other Coronavirus Infections
Infectious Disorders - Drug Targets Construction, Expression, Purification and Biotin Labeling of a Single Recombinant Multi-Epitope Antigen for Double-Antigen Sandwich ELISA to Detect Hepatitis C Virus Antibody
Protein & Peptide Letters Efficacy of Dexamethasone for the Treatment of COVID-19 Infection: A Perspective Review
Current Drug Delivery Insights into Novel Coronavirus Disease 2019 (COVID-19): Current Understanding, Research, and Therapeutic Updates
Recent Patents on Biotechnology Polyfunctionalized Pyrrole Derivatives: Easy Three-component Microwave-assisted Synthesis, Cytostatic and Antiviral Evaluation
Current Microwave Chemistry